1.
J Pediatr
; 102(4): 629-31, 1983 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-6834204
Assuntos
Amicacina/farmacologia , Antibacterianos/farmacologia , Gentamicinas/farmacologia , Doenças do Recém-Nascido/induzido quimicamente , Canamicina/análogos & derivados , Sulfato de Magnésio/efeitos adversos , Doenças Neuromusculares/induzido quimicamente , Tobramicina/farmacologia , Adolescente , Animais , Sinergismo Farmacológico , Feminino , Humanos , Recém-Nascido , Doenças do Recém-Nascido/terapia , Intubação Intratraqueal , Masculino , Camundongos , Camundongos Endogâmicos , Doenças Neuromusculares/terapia , Coelhos , Insuficiência Respiratória/induzido quimicamente , Insuficiência Respiratória/terapia
2.
J Pediatr
; 100(2): 272-6, 1982 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-7199083
RESUMO
To investigate the effects on the newborn infant of maternal magnesium therapy for treatment of pre-eclampsia, we studied 36 hypermagnesemic infants born to pre-eclamptic mothers treated with MgSO4, 18 neonates born to untreated pre-eclamptic mothers, and 25 infants born to normal mothers. Impairment of neuromuscular transmission, as well as neurobehavioral differences when compared to controls, were found in hypermagnesemic infants. Awareness of the changes produced in the neonate by magnesium is important for accurate clinical assessment of the infant's condition, as well as for anticipating the postnatal interaction of magnesium with other drugs administered during labor and delivery.